Amprius Technologies, Inc. Form 8-K Summary
Business Context and Reporting Period
Amprius Technologies, Inc. filed a Form 8-K dated March 6, 2023, reporting a management title change associated with the formation of two business units. The company develops and manufactures silicon-anode lithium-ion batteries. The filing was signed on March 9, 2023.
Management Change
- Jonathan Bornstein’s title changed from Chief Operating Officer to President of Amprius Lab.
- Mr. Bornstein will continue overseeing operations at the company’s laboratory and production facility in Fremont, California.
- His biographical information was incorporated by reference from the company’s December 2, 2022 Form S-1 prospectus.
- His compensation will not change as a result of the appointment.
Financial Metrics and Material Period Changes
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, guidance, or other financial metrics. It does not report financial results or a material change in financial performance versus a prior period.
Outlook, Risks, and Unusual Items
The filing does not provide new guidance, outlook commentary, risk disclosures, contingencies, or unusual financial items. The principal reported organizational change is the establishment of two business units and the related title reassignment.
Key Facts to Verify
- Confirm the scope, responsibilities, and operating objectives of the two newly formed business units.
- Monitor whether the organizational change affects Fremont laboratory or production operations.
- Verify in subsequent filings whether Mr. Bornstein’s responsibilities or compensation change.
- Review subsequent financial filings for the operational and financial effects of the business-unit structure.